This research investigates polyploid giant cancer cells, a highly treatment-resistant population responsible for cancer relapse. By studying their structural biology and dependence on lipid metabolism, the work identifies metabolic vulnerabilities that can be targeted alongside chemotherapy, offering a promising strategy to eliminate resistant cancer cells and improve long-term treatment outcomes.

This research investigates how melanoma switches between two gene states—one fast-growing and treatable, the other slow but highly invasive and responsible for brain metastases. By identifying genes that control this transition, the study aims to force melanoma into a more treatable form, improving therapeutic options and patient outcomes.

Breast cancer most often kills by spreading to the brain, where hormone therapies fail. This research reveals a signaling pathway that drives tumor growth in both pre- and postmenopausal settings. Identifying alternative activators of this pathway opens new therapeutic opportunities for deadly brain metastases.

Cancer cells survive extreme oxidative stress by importing lipoproteins that deliver vitamin E, a powerful antioxidant. This creates a fire-resistant shield that prevents ferroptotic cell death. Blocking vitamin E delivery or lipoprotein uptake removes this protection, revealing a new vulnerability that could influence tumor growth and treatment response.